利好！刚刚，证监会发布

Core Viewpoint - The China Securities Regulatory Commission (CSRC) is committed to enhancing the quality of the capital market by supporting qualified companies in various sectors, including traditional Chinese medicine and biomedicine, to issue and list stocks, while also promoting mergers and acquisitions to facilitate asset integration and industrial upgrades [2][3][4]. Group 1: Support for Specific Industries - The CSRC will actively support qualified traditional Chinese medicine and biomedicine companies in their stock issuance and listing processes [2]. - The CSRC aims to assist qualified companies in the western regions of China through mergers and acquisitions to promote asset integration and industrial upgrades [3]. - The CSRC plans to support qualified heating companies in issuing Real Estate Investment Trusts (REITs) to enhance asset management and promote effective investment [6]. Group 2: Market Mechanisms and Reforms - The CSRC will deepen the market-oriented reform of mergers and acquisitions, encouraging leading companies to engage in absorption mergers and utilize various financial instruments for mergers and acquisitions [4]. - The CSRC is working to optimize and expand the connectivity between mainland China and Hong Kong's financial markets, enhancing mechanisms such as stock and bond links [5]. Group 3: Current Market Conditions - The CSRC has determined that the current conditions do not support the establishment of a new securities exchange in Chongqing, citing the existing exchanges in Shanghai, Shenzhen, and Beijing as sufficient to meet market needs [7][8]. - The CSRC noted that the conditions for launching REITs-based ETFs are not yet fully met, as the REITs market is still in its early stages [9]. Group 4: Proposal Handling and Efficiency - In 2024, the CSRC handled a total of 424 proposals from the National People's Congress and the Chinese People's Political Consultative Conference, focusing on enhancing the stability of the capital market and addressing public concerns [10].